Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,072 | 19,734 | 9,290 | 42,060 | 37,576 |
| Depreciation Amortization | 29,416 | 19,849 | 10,245 | 22,229 | 16,345 |
| Income taxes - deferred | -4,462 | -6,485 | 1,355 | -6,744 | -4,047 |
| Accounts payable and accrued liabilities | 4,131 | 5,813 | 1,975 | -1,269 | -3,044 |
| Other Working Capital | -24,904 | -13,974 | -9,499 | -13,003 | -7,502 |
| Other Operating Activity | 8,486 | 2,763 | 2,116 | 17,719 | 15,879 |
| Operating Cash Flow | $25,739 | $27,700 | $15,482 | $60,992 | $55,207 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,028 | -7,830 | -2,803 | -10,009 | -8,207 |
| Net Acquisitions | N/A | N/A | N/A | -203,336 | N/A |
| Other Investing Activity | -207 | -207 | -1,072 | 255 | 255 |
| Investing Cash Flow | $-11,235 | $-8,037 | $-3,875 | $-213,090 | $-7,952 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,600 | 1,600 | 0 | 23,687 | 689 |
| Common Stock Repurchased | -27,507 | -27,507 | -12,300 | -9,444 | -9,444 |
| Dividend Paid | -1,258 | -379 | N/A | N/A | N/A |
| Other Financing Activity | -26,891 | -26,791 | -2,167 | -4,690 | -4,622 |
| Financing Cash Flow | $-54,056 | $-53,077 | $-14,467 | $9,553 | $-13,377 |
| Exchange Rate Effect | 3,197 | 3,032 | 719 | -6,193 | 617 |
| Beginning Cash Position | 184,508 | 184,508 | 184,508 | 333,246 | 333,246 |
| End Cash Position | 148,153 | 154,126 | 182,367 | 184,508 | 367,741 |
| Net Cash Flow | $-36,355 | $-30,382 | $-2,141 | $-148,738 | $34,495 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,739 | 27,700 | 15,482 | 60,992 | 55,207 |
| Capital Expenditure | -11,028 | -7,830 | -2,803 | -10,073 | -8,271 |
| Free Cash Flow | 14,711 | 19,870 | 12,679 | 50,919 | 46,936 |